Related Experiment Videos

Pradimicin, a mannose-binding antibiotic, induced carbohydrate-mediated apoptosis in U937 cells

T Oki1, Y Yamazaki, T Furumai

  • 1Toyama Prefectural University, Biotechnology Research Center, Japan. oki@pu-toyama.ac.jp

Insights

The antifungal pradimicin analog BMY-28864 triggers apoptosis in U937 cells. This cell death, induced by 1-deoxymannojirimycin, involves DNA fragmentation and apoptotic bodies.

Area of Science:

  • Pharmacology
  • Cell Biology
  • Mycology

Background:

  • Pradimicin (PRM) is a mannose-binding antifungal antibiotic.
  • PRM requires calcium to recognize D-mannoside structures.

Purpose of the Study:

  • To investigate the effect of BMY-28864, a semi-synthetic PRM analog, on U937 cells.
  • To determine if BMY-28864 induces apoptosis in U937 cells, particularly after incubation with 1-deoxymannojirimycin (DMJ).

Main Methods:

  • U937 cells were incubated with 1-deoxymannojirimycin (DMJ).
  • BMY-28864 was administered to DMJ-treated U937 cells.
  • Apoptosis was assessed by observing morphological changes and DNA fragmentation.

Main Results:

  • BMY-28864 induced apoptosis in U937 cells pre-incubated with DMJ.
  • Key apoptotic features, including the formation of apoptotic bodies, were observed.
  • DNA fragmentation was a characteristic finding in the apoptotic cells.

Conclusions:

  • BMY-28864, a pradimicin analog, effectively induces apoptosis in U937 cells.
  • The induction of apoptosis is potentiated by prior incubation with 1-deoxymannojirimycin.
  • Morphological and molecular evidence confirms apoptosis, highlighting BMY-28864's potential cytotoxic effects.

Related Concept Videos